Sernova Corp. (CVE:SVA)’s share price traded up 8.8% on Monday . The stock traded as high as C$0.19 and last traded at C$0.19. 657,700 shares were traded during mid-day trading, an increase of 208% from the average session volume of 213,657 shares. The stock had previously closed at C$0.17.
The company has a market cap of $27.20 million and a P/E ratio of -7.08.
TRADEMARK VIOLATION NOTICE: This article was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2019/02/11/sernova-sva-trading-8-8-higher.html.
Sernova Company Profile (CVE:SVA)
Sernova Corp., a regenerative medicine company, engages in the development and commercializing of its proprietary Cell Pouch and associated technologies. The company's proprietary Cell Pouch and associated technologies include therapeutic cells and local immune protection. It focuses on developing medical devices and combination products for patients with chronic metabolic, neurological, and haematological diseases.
See Also: What is the Coverage Ratio?
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.